The same type of problems is also found in patients in a more advanced phase of the disease, when insulin has already been included in the therapeutic plan, aggravated by the fact that complex administration schedules require several daily injections, considered by 23.1% of patients with T2D as a psychophysical obstacle to daily life [2]. The gene discussed is INS; the disease is type 2 diabetes mellitus.